-
2023
-
Mirati’s Krazati Gets Accelerated Approval for NSCLC
-
Rare Disease Moonshot launched at European Health Summit
-
Merck and Moderna’s mRNA cancer vaccine aces its first efficacy trial
-
FDA Advisors Reject Cytokinetics’ Heart Failure Candidate
-
ACELYRIN acquires ValenzaBio, strengthens immunology position
-
Intranasal Therapy for Major Depressive Disorder Gets Fast Track Status
-
Prime to Cover Biosimilars Alongside Humira
-
Kintara’s VAL-083 Gets Orphan Drug Status for Rare Childhood Cancer
-
Neurophth Receives IND Clearance from FDA for AAV-ND1 Gene Therapy of LHON
-
FDA Approves First Gene Therapy for Specific Form of Bladder Cancer